Suppr超能文献

世界为应对未来大流行和国际关注的突发公共卫生事件做准备:多种多边获取与惠益分享机制的比较以及世卫组织一项针对具有大流行潜力病原体的新机制对日本获取与惠益分享政策的影响

The world preparing for future pandemics and public health emergencies of international concern: Comparison of various multilateral access and benefit-sharing mechanisms and the impact of a new WHO mechanism for pathogens with pandemic potential on Japanese access and benefit-sharing policy.

作者信息

Nakamura Saki, Matsuo Makiko

机构信息

Institute for Future Initiatives, The University of Tokyo, Tokyo, Japan.

Graduate School of Public Policy, The University of Tokyo, Tokyo, Japan.

出版信息

Glob Health Med. 2025 Apr 30;7(2):127-140. doi: 10.35772/ghm.2025.01000.

Abstract

Currently, there is a member-state-led discussion in the Intergovernmental Negotiating Body of the World Health Organization (WHO) to draft and negotiate a convention, agreement, or other international instrument under the Constitution of the WHO to strengthen global pandemic prevention, preparedness, and response (WHO CA+). An access and benefit-sharing (ABS) mechanism for pathogens is likely to be a key element of this instrument, as it may provide legal certainty for rapid pathogen sharing and global access to medical countermeasures against future pandemics and in some cases public health emergencies of international concern, which are expected to be provided to countries in need. A multilateral ABS mechanism may resolve issues arising from the bilateral nature of the current ABS mechanism established under the Nagoya Protocol (which requires recipients to decipher the complex web of ABS legislation, thereby preventing rapid access to pathogens), and may also improve uneven global access to medical countermeasures during pandemics. This study analyzes the ongoing WHO discussion on ABS mechanisms while reviewing other examples of such mechanisms, including those outside the health sector. Additionally, there is a growing global interest in mapping national policies on ABS, as discussions on international policies are ongoing in multiple fora. This study furthermore introduces Japan's ABS policy, which is not widely known, and explores how the new WHO mechanism could affect Japan, namely highlighting the importance and the challenges of participating in such a system for industry and academia in the context of a developed country.

摘要

目前,世界卫生组织(WHO)政府间谈判机构正在进行一场由成员国主导的讨论,旨在根据WHO章程起草并协商一项公约、协定或其他国际文书,以加强全球大流行预防、防范和应对(WHO CA+)。病原体的获取和惠益分享(ABS)机制很可能是该文书的关键要素,因为它可为病原体的快速共享以及全球获取针对未来大流行以及某些情况下国际关注的突发公共卫生事件的医疗应对措施提供法律确定性,这些应对措施预计将提供给有需要的国家。多边ABS机制可能会解决因根据《名古屋议定书》设立的现行ABS机制的双边性质而产生的问题(该机制要求接受方解读复杂的ABS立法网络,从而阻碍了对病原体的快速获取),还可能改善大流行期间全球获取医疗应对措施不均衡的状况。本研究分析了WHO目前关于ABS机制的讨论,同时回顾了此类机制的其他实例,包括卫生部门以外的实例。此外, 随着多个论坛正在进行关于国际政策的讨论,全球对梳理各国ABS政策的兴趣也与日俱增。本研究还介绍了鲜为人知的日本ABS政策,并探讨新的WHO机制可能如何影响日本,即在发达国家背景下,突出该系统对产业界和学术界的重要性以及参与其中所面临的挑战。

相似文献

3
Global patterns in access and benefit-sharing: a comprehensive review of national policies.
BMJ Public Health. 2025 Mar 4;3(1):e001800. doi: 10.1136/bmjph-2024-001800. eCollection 2025 Jan.
4
Equity in the Pandemic Treaty: Access and Benefit-Sharing as a Policy Device or a Rhetorical Device?
J Law Med Ethics. 2023;51(1):217-220. doi: 10.1017/jme.2023.59. Epub 2023 May 25.
5
Access and Benefit Sharing Under the Nagoya Protocol-? Six Latin American Case Studies Assessing Opportunities and Risk.
Front Pharmacol. 2020 Jun 8;11:765. doi: 10.3389/fphar.2020.00765. eCollection 2020.
6
Pandemic treaty as an instrument to strengthen global health security: Global health diplomacy at its crux.
Health Promot Perspect. 2024 Mar 14;14(1):9-18. doi: 10.34172/hpp.42744. eCollection 2024 Mar.
9
Explanation of the Nagoya Protocol on Access and Benefit Sharing and its implication for microbiology.
Microbiology (Reading). 2017 Mar;163(3):289-296. doi: 10.1099/mic.0.000425. Epub 2017 Mar 29.
10
Balanced Options for Access and Benefit-Sharing: Stakeholder Insights on Provider Country Legislation.
Front Plant Sci. 2019 Oct 1;10:1175. doi: 10.3389/fpls.2019.01175. eCollection 2019.

本文引用的文献

1
Global patterns in access and benefit-sharing: a comprehensive review of national policies.
BMJ Public Health. 2025 Mar 4;3(1):e001800. doi: 10.1136/bmjph-2024-001800. eCollection 2025 Jan.
2
3
Advances in COVID-19 mRNA vaccine development.
Signal Transduct Target Ther. 2022 Mar 23;7(1):94. doi: 10.1038/s41392-022-00950-y.
4
Nagoya Protocol and Infectious Diseases: Hindrance or Opportunity?
Front Public Health. 2020 Jun 16;8:238. doi: 10.3389/fpubh.2020.00238. eCollection 2020.
5
Policy opportunities to enhance sharing for pandemic research.
Science. 2020 May 15;368(6492):716-718. doi: 10.1126/science.abb9342.
6
When the cure kills-CBD limits biodiversity research.
Science. 2018 Jun 29;360(6396):1405-1406. doi: 10.1126/science.aat9844.
7
The global health law trilogy: towards a safer, healthier, and fairer world.
Lancet. 2017 Oct 21;390(10105):1918-1926. doi: 10.1016/S0140-6736(17)31261-8. Epub 2017 May 15.
8
Treaty to stop biopiracy threatens to delay flu vaccines.
Nature. 2017 Feb 8;542(7640):148. doi: 10.1038/542148a.
9
Explanation of the Nagoya Protocol on Access and Benefit Sharing and its implication for microbiology.
Microbiology (Reading). 2017 Mar;163(3):289-296. doi: 10.1099/mic.0.000425. Epub 2017 Mar 29.
10
Developing Global Norms for Sharing Data and Results during Public Health Emergencies.
PLoS Med. 2016 Jan 5;13(1):e1001935. doi: 10.1371/journal.pmed.1001935. eCollection 2016 Jan.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验